• Hemispherx News 02

CEO Roadshow Interviews Hemispherx Thomas K. Equels

April 4th, 2019|

CEO Roadshow Interviews Hemispherx Thomas K. Equels Hemispherx CEO Thomas K. Equels recently sat down with Mike Elliot of CEO Roadshow to provide an update on everything the company is working at [...]

  • Hemispherx News 04

Introducing You to the First Ampligen Quarterly Update

March 25th, 2019|

Introducing You to the First Ampligen Quarterly Update Today we announced significant progress in our Ampligen pancreatic cancer program and our multiple Ampligen plus checkpoint blockade immuno-oncology programs. We also announced the [...]

  • Hemispherx News 03

A Major New Ovarian Cancer Clinical Study Has Begun

February 11th, 2019|

A Major New Ovarian Cancer Clinical Study Has Begun Hemispherx recently announced an important new step in its efforts to develop Ampligen as a powerful cancer-fighting therapy. The company announced the start [...]

SHOW ALL